PCK 6.25% 3.4¢ painchek ltd

PainChek General Discussion, page-15234

  1. 1,155 Posts.
    lightbulb Created with Sketch. 435
    A little from the International Journal of Pharmaceutical Svience .

    There are a considerable number of pain assessment tools available for use with the elderly cognitive impaired population. We cannot at present recommend any particular tool for use in any clinical setting, due to the lack of comprehensive evidence ........

    PainchekTM is a comprehensive and evidence-based pain management system. It is considered as a valid and reliable pain assessment tool which is the world-first pain assessment medical device that uses artificial intelligence to assess and score pain levels .......

    PainChek has regulatory clearance in Australia and Europe. Yet it is not developed in India and other countries. All the countries should allow PainChek to further increase visibility and accelerate future growth, in order to continue improving the quality of life for people with Pain.


    Great to keep uncovering these articles. Matter of all the holes in the cheese lining up then look out ...


    http://globalresearchonline.net/journalcontents/v61-2/16.pdf






 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.002(6.25%)
Mkt cap ! $55.61M
Open High Low Value Volume
3.2¢ 3.4¢ 3.2¢ $26.85K 817.4K

Buyers (Bids)

No. Vol. Price($)
1 295636 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 70943 1
View Market Depth
Last trade - 15.43pm 17/09/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.